Okinaka Y, Kageyama S, Nishizawa K, et al. - This study’s findings demonstrate that organized prostate-specific antigen (PSA) screening contributes to increasing the number of patients diagnosed with early-stage cancer who can be treated curatively.

• Researchers examined 984 newly diagnosed prostate cancer patients in the 2 years 2012 and 2017.

• Among these patients, 954 (97%) were opportunistically tested (i.e., not as part of an organized screening system), with the remaining 29 (3%) measured as part of an organized screening program.

• A higher initial PSA value was observed in patients with the former group than in the organized screening group (median: 11.49 vs. 5.67 ng/ml). As per the findings, they also had worse clinical features, including higher Gleason score and TNM stage.

• In the organized screening group, more patients were treated curatively than in the nonorganized screening group in terms of the primary treatment.

• They found similar results in a subanalysis of the patients of age 50–69 years.